Clinical Trial Update: A Study of BEN301 Injection in the Treatment of Autoimmune Diseases [EARLY_Phase 1]

View source ↗

Summary

Early Phase 1 clinical trial update for BEN301 injection evaluating safety in autoimmune diseases including systemic sclerosis, rheumatoid arthritis, Sjögren's …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Inflammatory Myopathy
• Rheumatoid Arthritis
• Sjögren Syndrome
• Systemic Sclerosis

Drugs mentioned

• BEN301 Injection

Snippet

Sponsor: Beijing Boren Hospital | Conditions: SSC RA SS IIM | EARLY_Phase 1 | Status: NOT_YET_RECRUITING